Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2019/20 group results

May 14 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            288.53          261.55         289.50                 
                 (+10.3 pct)     (-6.6 pct)     (+0.3 pct)               
  Operating         21.46           31.21          20.00                 
                 (-31.2 pct)     (-15.6 pct)    (-6.8 pct)               
  Recurring         25.01           40.85          23.00                 
                 (-38.8 pct)     (-3.1 pct)     (-8.0 pct)               
  Net
  Net               20.53           48.59          13.00                 
                 (-57.7 pct)     (+53.4 pct)    (-36.7 pct)              
  EPS            257.23 yen      608.80 yen     162.89 yen               
  EPS Diluted    256.93 yen      608.22 yen                              
  Ann Div        110.00 yen      120.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         60.00 yen       70.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news